Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia – the occurrence of retinoic acid syndrome is a risk factor (original) (raw)

APL

Leukemia volume 13, pages 1406–1408 (1999)Cite this article

Abstract

All-trans retinoic acid (ATRA) is now a standard agent for remission induction of acute promyelocytic leukemia (APL). Recently, extramedullary relapse, which was a rare condition in APL patients after chemotherapy alone, was reported with an increased frequency after ATRA treatment. However, it is not yet clear whether ATRA truly increases the risk of extramedullary recurrence and what are the risk factors. In this study, three of 13 patients with recurrent APL after prior treatment of ATRA were found to have extramedullary involvement, compared with none in 11 recurrent patients previously treated with chemotherapy alone (estimated relative risk 2.100, 95% confidence interval 1.341–3.289). Furthermore, in the former group of patients, the development of retinoic acid (RA) syndrome during prior induction treatment was significantly associated with extramedullary involvement at relapse (three in five patients with RA syndrome vs none in eight without the syndrome, estimated relative risk 5.000, 95% confidence interval 1.448–17.271). In conclusion, ATRA may predispose APL patients to extramedullary involvement at relapse and the occurrence of RA syndrome is a risk factor for it. Further studies are needed to confirm these findings. It also remains to be clarified whether treatment modification is necessary in patients who develop RA syndrome during ATRA treatment.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Hematology Division of the Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
    B-S Ko, J-L Tang, M Yao & H-F Tien
  2. Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
    Y-C Chen, C-H Wang & M-C Shen

Authors

  1. B-S Ko
  2. J-L Tang
  3. Y-C Chen
  4. M Yao
  5. C-H Wang
  6. M-C Shen
  7. H-F Tien

Rights and permissions

About this article

Cite this article

Ko, BS., Tang, JL., Chen, YC. et al. Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia – the occurrence of retinoic acid syndrome is a risk factor.Leukemia 13, 1406–1408 (1999). https://doi.org/10.1038/sj.leu.2401495

Download citation

Keywords

This article is cited by